Centessa Pharmaceuticals (CNTA) Stock Research

CNTA

· CNTA

Over a week ago

Two new option listings and option delistings on July 21st

+12

Jul 21, 8:30 AM

Alkermes price target raised by $18 at Stifel, here's why

Jul 20, 8:18 AM

Centessa announces High Court approval for acquisition by Eli Lilly

Jun 22, 4:23 PM

Centessa gets FDA orphan drug designation for cleminorexton

CNTA

Jun 4, 2:57 PM

Alkermes price target raised by $5 at Needham, here's why

May 6, 9:45 AM

Eli Lilly price target raised by $20 at Guggenheim, here's why

Apr 22, 7:17 AM

Centessa just downgraded at Wells Fargo, here's why

CNTA

Apr 20, 5:12 AM

Centessa just downgraded at Truist, here's why

CNTA

Apr 12, 8:44 PM

Centessa just downgraded at Guggenheim, here's why

CNTA

Apr 1, 11:58 AM

Disney upgraded, Nike downgraded: Wall Street's top analyst calls

+29

Apr 1, 9:46 AM

Centessa just downgraded at LifeSci Capital, here's why

CNTA

Apr 1, 7:30 AM

Centessa just downgraded at Leerink, here's why

CNTA

Apr 1, 6:12 AM

What You Missed On Wall Street On Tuesday

+26

Mar 31, 4:25 PM

Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink

Mar 31, 1:18 PM

Centessa acquisition 'may help rouse' Alkermes shares, says RBC Capital

Mar 31, 12:41 PM

Alkermes jumps after Eli Lilly acquires peer Centessa

Mar 31, 12:07 PM

Centessa rises 44.8%

CNTA

Mar 31, 12:00 PM

Midday Fly By: Nvidia invests $2B in Marvell, Biogen to acquire Apellis

+27

Mar 31, 11:58 AM

Centessa just downgraded at Wolfe Research, here's why

CNTA

Mar 31, 11:07 AM

Centessa deal 'fits' for Eli Lilly, says BofA

Mar 31, 10:27 AM

Centessa rises 45.7%

CNTA

Mar 31, 10:00 AM

Centessa just downgraded at B. Riley, here's why

CNTA

Mar 31, 9:49 AM

Video: Deals in food and pharmaceuticals headline busy morning of M&A

Mar 31, 9:02 AM

Morning Movers: Marvell jumps following Nvidia investment, AI factory pact

+11

Mar 31, 8:59 AM

Centessa downgraded to Equal Weight from Overweight at Stephens

Mar 31, 8:22 AM

Charts

Over a week ago

Two new option listings and option delistings on July 21st

+12

Jul 21, 8:30 AM

Alkermes price target raised by $18 at Stifel, here's why

Jul 20, 8:18 AM

Centessa announces High Court approval for acquisition by Eli Lilly

Jun 22, 4:23 PM

Centessa gets FDA orphan drug designation for cleminorexton

CNTA

Jun 4, 2:57 PM

Alkermes price target raised by $5 at Needham, here's why

May 6, 9:45 AM

Eli Lilly price target raised by $20 at Guggenheim, here's why

Apr 22, 7:17 AM

Centessa just downgraded at Wells Fargo, here's why

CNTA

Apr 20, 5:12 AM

Centessa just downgraded at Truist, here's why

CNTA

Apr 12, 8:44 PM

Centessa just downgraded at Guggenheim, here's why

CNTA

Apr 1, 11:58 AM

Disney upgraded, Nike downgraded: Wall Street's top analyst calls

+29

Apr 1, 9:46 AM

Centessa just downgraded at LifeSci Capital, here's why

CNTA

Apr 1, 7:30 AM

Centessa just downgraded at Leerink, here's why

CNTA

Apr 1, 6:12 AM

What You Missed On Wall Street On Tuesday

+26

Mar 31, 4:25 PM

Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink

Mar 31, 1:18 PM

Centessa acquisition 'may help rouse' Alkermes shares, says RBC Capital

Mar 31, 12:41 PM

Alkermes jumps after Eli Lilly acquires peer Centessa

Mar 31, 12:07 PM

Centessa rises 44.8%

CNTA

Mar 31, 12:00 PM

Midday Fly By: Nvidia invests $2B in Marvell, Biogen to acquire Apellis

+27

Mar 31, 11:58 AM

Centessa just downgraded at Wolfe Research, here's why

CNTA

Mar 31, 11:07 AM

Centessa deal 'fits' for Eli Lilly, says BofA

Mar 31, 10:27 AM

Centessa rises 45.7%

CNTA

Mar 31, 10:00 AM

Centessa just downgraded at B. Riley, here's why

CNTA

Mar 31, 9:49 AM

Video: Deals in food and pharmaceuticals headline busy morning of M&A

Mar 31, 9:02 AM

Morning Movers: Marvell jumps following Nvidia investment, AI factory pact

+11

Mar 31, 8:59 AM

Centessa downgraded to Equal Weight from Overweight at Stephens

Mar 31, 8:22 AM

Company News

Charts

CNTA

· CNTA

Company News

Charts

CNTA

· CNTA